Catherine Novack

Stock Analyst at Jones Trading

(1.24)
# 3,667
Out of 5,044 analysts
21
Total ratings
27.78%
Success rate
-7.26%
Average return

Stocks Rated by Catherine Novack

Aardvark Therapeutics
Oct 1, 2025
Initiates: Buy
Price Target: $33
Current: $12.00
Upside: +175.00%
Dyne Therapeutics
Jun 26, 2025
Initiates: Buy
Price Target: $30
Current: $24.29
Upside: +23.51%
Capricor Therapeutics
Jun 25, 2025
Maintains: Buy
Price Target: $40$29
Current: $6.18
Upside: +369.26%
Femasys
May 13, 2025
Maintains: Buy
Price Target: $10$6
Current: $0.66
Upside: +808.82%
Rallybio
Apr 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.62
Upside: -
Palvella Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $45
Current: $73.50
Upside: -38.78%
ProQR Therapeutics
Feb 12, 2025
Initiates: Buy
Price Target: $11
Current: $2.85
Upside: +285.96%
Korro Bio
Nov 18, 2024
Initiates: Buy
Price Target: $130
Current: $40.08
Upside: +224.35%
Equillium
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.35
Upside: -
Wave Life Sciences
Sep 25, 2024
Maintains: Buy
Price Target: $12$16
Current: $7.59
Upside: +110.80%
Initiates: Buy
Price Target: $14
Current: $4.35
Upside: +221.84%
Maintains: Buy
Price Target: $5$13
Current: $2.03
Upside: +540.39%
Initiates: Buy
Price Target: $10
Current: $9.49
Upside: +5.37%
Initiates: Buy
Price Target: $22
Current: $3.11
Upside: +607.40%
Downgrades: Hold
Price Target: n/a
Current: $6.25
Upside: -
Initiates: Buy
Price Target: $160
Current: $0.58
Upside: +27,344.25%